Hydronephrosis Disease

BASICS

DESCRIPTION
Unilateral or bilateral dilatation of the urinary tract at any level secondary to intrinsic and/or extrinsic obstruction to urine flow. May also be functional.
  • System(s) affected: Renal/Urologic
  • Genetics: Unknown
  • Incidence/Prevalence in USA:
    • Children 2 in 100
    • Adults 3.8 in 100
  • Predominant age: All ages. Bimodal peaks: congenital and over age 60.
  • Predominant sex:
    • Age 0 - 20 years: Male = Female
    • Age 20 to 60 years: Female > Male
    • Age greater than 60 years: Male > Female
SIGNS AND SYMPTOMS
  • Varies with acute or chronic presentation
  • Chronic hydronephrosis may be completely asymptomatic
  • "Colic" referred to vulva or to testicle (lithiasis) with acute obstruction
  • Change in urine output (anuria, polyuria, intermittent variation in urine volume)
  • Hesitancy
  • Dribbling
  • Urinary tract infections
  • Decreased force of urine or interrupted stream
  • Nocturia
  • Abdominal mass
  • Frequency and urgency
  • Thirst
  • Hypertension (may be accelerated)
  • Edema
  • After relief - post obstructive diuresis
  • Epididymitis
  • Acute or chronic urinary retention
CAUSES
  • Intrinsic, congenital
    • Stenosis (ureteral, urethral and meatal)
    • Adynamic ureter
    • Spinal cord defects, e.g., spina bifida
    • Duplication of the ureter
    • Ureterocele
  • Intrinsic, acquired
    • Renal lithiasis (most common)
    • Neoplasm (renal, ureteral or bladder)
    • Papillary necrosis with sloughed papilla
    • Ureterocele
    • Trauma
    • Blood clot
    • Fungus ball
    • Granuloma (tuberculosis)
    • Neurogenic bladder
    • Other nervous system diseases - tabes dorsalis, multiple sclerosis, diabetes mellitus, traumatic spinal cord injury
    • Anticholinergics
    • Phimosis, Ureteral valve, Polyp or stricture
    • Schistosomiasis (hematobium)
    • Wegener's granulomatosis
    • Psychogenic polydipsia
    • Imperforate hymen
  • Extrinsic
    • Retroperitoneal - neoplasm, blood, abscess, fibrosis, aneurysm
    • Crohn's disease
    • Lymphocele, hydrocele
    • Gynecologic - gravid uterus, endometriosis, pelvic inflammatory disease, abscess, cyst, iatrogenic-ureteral injury during surgery, gynecologic malignancy, uterine prolapse
    • Sjögren's syndrome (pseudolymphoma)
  • Functional or non-mechanical - congenital
    • Mega-ureter
    • Prune belly syndrome
    • Extra renal pelvis
  • Functional or non-mechanical - other
    • Diabetes insipidus
    • Diuretics
    • Pregnancy
    • Vesicoureteral reflux
    • Postobstructive residual
    • Postsurgical: post ureteral anastomosis
    • Progestational agents
RISK FACTORS
  • Radiation
  • Prostatic hypertrophy and/or malignancy
  • Renal lithiasis
  • Methysergide
  • Analgesic abuse (papillary necrosis, transitional cell carcinoma)
  • Sickle cell anemia (papillary necrosis)
  • Diabetes mellitus (papillary necrosis)
  • Bleeding diathesis
  • Anticholinergics
  • See Causes

DIAGNOSIS

LABORATORY
  • May be completely normal
  • Azotemia
  • Hyperkalemia
  • Metabolic acidosis (with and without anion gap)
  • Hypernatremia (nephrogenic diabetes insipidus)
  • Urine analysis - hematuria, crystals, bacteriuria
  • Decreased urine concentrating ability
  • Polycythemia (rare)
  • Anemia of chronic renal disease

Drugs that may alter lab results: Nephrotoxins may aggravate azotemia (nonsteroidal anti-inflammatory drugs, immunosuppressants, aminoglycosides, iodinated contrast, anticholinergics)
Disorders that may alter lab results: N/A

PATHOLOGICAL FINDINGS
  • Thin renal cortex
  • Renal tubular atrophy
  • Medullary destruction
SPECIAL TESTS
  • Kidney and urinary bladder (KUB)
  • Voiding cystourethrogram
  • Measurement post void residual
  • Ultrasound prostate with biopsy if nodule found
  • Prostatic specific antigen (malignancy); controversial - yes (American Cancer Society), no (National Cancer Institute)
  • Prenatal sonography
  • Rectal examination in males age > 50
IMAGING
  • Unenhanced helical CT for lithiasis
  • Ultrasound - abnormal renal function, cortical thinning, ureteral dilatation
  • IVP with tomograms (normal renal function): Renal pelvis dilatation
  • Renal flow scan, diuretic renogram
  • CT scan; MRI
  • Pulsed and color Doppler
  • Diuretic enhanced duplex Doppler sonography
DIAGNOSTIC PROCEDURES
  • To determine location and etiology:
    • Cystoscopy/retrograde pyelography
    • Antegrade pyelography
    • Loopography (obstruction with ureteral diversion)

TREATMENT

APPROPRIATE HEALTH CARE

Outpatient

GENERAL MEASURES
  • Females: Pelvic pap smear for potential gynecologic malignancy. Appropriate work-up for recurrent urinary tract infections.
  • Males: Anatomic study of the urinary tract for any urinary tract infection, appropriate review of systems and digital rectal exam for prostatic hypertrophy. Prostatic specific antigen, acid phosphatase, rectal transducer ultrasound of prostate for prostatic enlargement.
  • Relief of obstruction for preservation of renal function:
    • Foley catheter for prostatic hypertrophy
    • Transurethral resection of the prostate gland for prostatic hypertrophy
    • Nephrostomy tube
    • Pyeloplasty
    • Surgical diversion of ureters
    • Ureteral stents
    • Urolithiasis - extra corporeal shock wave lithotripsy, percutaneous nephrolithotomy, ureteroscopic stone removal or surgical removal. Treatment depends on stone size.
    • Nephrectomy
  • Neurogenic hydronephrosis:
    • Frequent voiding
    • Double voiding
    • Suprapubic pressure
    • Intermittent catheterization
    • Cholinergics
    • Surgical reimplantation of ureters
    • Antibiotics, when needed for infection
  • Uremia:
    • Dialysis
    • Hyperkalemia (calcium, Kayexalate, insulin and glucose)
    • Treat acidosis (1-2 teaspoons sodium bicarbonate tid or Shohl's solution)
    • Treat hypocalcemia (calcium acetate tablets 1-3 with meals; vitamin D - dihydrotachysterol 0.2 mg po every day)
SURGICAL MEASURES

see General Measures

ACTIVITY

Fully active

DIET
  • If not uremic, no restriction
  • When uremic - protein, salt, potassium restriction as needed
  • For stone-formers, increased oral fluids
PATIENT EDUCATION

Printed material available from National Kidney Foundation, 30 East 33rd, St., Ste. 1100, New York, New York, 10016 (800)622-9010. "What Everyone Should Know About Kidneys and Kidney Disease" (Order #01-01 BP English, #01-02 BP Spanish); also Urinary Tract Obstructions. How they Can Affect You.

FOLLOW UP

PREVENTION/AVOIDANCE
  • Avoid anticholinergics when obstruction present
  • Avoid dehydration with lithiasis
  • Drug therapy appropriate to prevent future calculi (e.g., allopurinol for uric acid stones)
POSSIBLE COMPLICATIONS
  • Urinary tract infection from instrumentation
  • Fibrosis from radiation for pelvic malignancy
  • Obstruction from stone fragments on lithotripsy
  • Postoperative bleeding
EXPECTED COURSE AND PROGNOSIS
  • Contingent on relief of obstruction and residual renal function
  • Excellent course and prognosis with relief of obstruction and restoration of normal renal function
  • Nonmechanical ureteropelvic junction (UPJ) obstruction has a good prognosis
  • Reflux with pyelonephritis worsens prognosis significantly
  • Poor if obstruction secondary to advanced malignancy

MISCELLANEOUS

ASSOCIATED CONDITIONS

See causes

AGE-RELATED FACTORS

Pediatric: Hydronephrosis most often congenital
Geriatric: In males, most often due to prostatic enlargement
Others: N/A

PREGNANCY

Frequent temporary cause of hydronephrosis

OTHER NOTES

N/A

ABBREVIATIONS

N/A

Clinical Investigations

ROLE OF HOMOEOPATHY

Copyright © 2025 Selkey. All Rights Reserved.